Security key
745848101
- Security type / class
- Equity / COM
- Total 13F shares
- 35,870,967
- Total 13F value
- $243,565,337
- Share change
- +393,889
- Put/Call ratio
- 42591%
- SEC-reported price per share
- $6.79
- Number of holders
- 117
- Value change
- +$1,640,704
- Number of buys
- 54
- Number of sells
- 49
- Shares outstanding
- 42,967,164
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
117
Top holders
10
LUNG full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Pulmonx Corp SEC filings
Pulmonx Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 745848101
Recent filing periods:
Ownership snapshot
Top reported holders of LUNG - Pulmonx Corp - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BOSTON SCIENTIFIC CORP
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $47,054,131
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
PRIMECAP MANAGEMENT CO/CA/ has the largest disclosed position value at $47.05M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Disclosed position value
Top 5
BOSTON SCIENTIFIC CORP
$19.54M
PRIMECAP MANAGEMENT CO/CA/
$47.05M
MORGAN STANLEY
$31.41M
BlackRock, Inc.
$23.18M
VANGUARD GROUP INC
$18.89M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BOSTON SCIENTIFIC CORP |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$19,538,832
1,488,106 shares
|
— | 13 Jul 2021 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
—
denominator unverified
|
$47,054,131
5,676,011 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$31,410,360
3,788,945 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$23,175,201
2,795,561 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$18,892,123
2,278,905 shares
|
— | 30 Sep 2024 |
| DEUTSCHE BANK AG\ |
13F
Company
|
—
denominator unverified
|
$9,300,054
1,121,840 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
117
Shares
35,870,967
Rows available
117
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
112
Q4 2024 holders
117
Holder diff
5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend